RYRIX | USLUX | RYRIX / USLUX | |
Total Expense Ratio | 1.40 | 1.75 | 80% |
Annual Report Gross Expense Ratio | 1.43 | 1.95 | 73% |
Fund Existence | 27 years | 31 years | - |
Gain YTD | 0.111 | 2.454 | 5% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000 | 50% |
Min. Initial Investment IRA | 1000 | N/A | - |
Net Assets | 7.49M | 49.2M | 15% |
Annual Yield % from dividends | 0.00 | 0.55 | - |
Returns for 1 year | 7.40 | 0.04 | 19,387% |
Returns for 3 years | 45.40 | 35.74 | 127% |
Returns for 5 years | 41.52 | 43.91 | 95% |
Returns for 10 years | 93.85 | 0.09 | 102,482% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LFGSX | 37.01 | -0.41 | -1.10% |
Lord Abbett Focused Growth R4 | |||
VRTTX | 509.88 | -6.05 | -1.17% |
Vanguard Russell 3000 Index I | |||
RGAAX | 68.39 | -0.83 | -1.20% |
American Funds Growth Fund of Amer R1 | |||
GCIEX | 7.33 | -0.10 | -1.35% |
Gabelli Equity Income I | |||
USTCX | 28.34 | -0.53 | -1.84% |
Victory Science & Technology Class A |